[Mechanism of action of 1,4 bis (3'-piperidinopropine-1'-yl-1') benzol on the heart].
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001001:Anura; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000517:prevention & control*; D001555:Benzene Derivatives / Q000494:pharmacology* / Q000627:therapeutic use; D002415:Cats; D003331:Coronary Vessels / Q000601:surgery; D003864:Depression, Chemical; D004285:Dogs; D004562:Electrocardiography; D006321:Heart / Q000187:drug effects*; D006323:Heart Arrest / Q000517:prevention & control*; D009206:Myocardium / Q000032:analysis*; D010946:Plants, Medicinal / Q000037:antagonists & inhibitors*; D011188:Potassium / Q000032:analysis; D011342:Procainamide / Q000494:pharmacology*; D011817:Rabbits; D012964:Sodium / Q000037:antagonists & inhibitors; D013268:Stimulation, Chemical; D013328:Strophanthins / Q000037:antagonists & inhibitors*
D000889:Anti-Arrhythmia Agents; D001555:Benzene Derivatives; D013328:Strophanthins; D012964:Sodium; D011342:Procainamide; D011188:Potassium
K mekhanizmu deistviia 1,4 bis (3'-piperidinopropin-1'-il-1') benzola na serdtse.